However, several studies reported contrasting data on the concentrations of C3, C4, and of CH50 activity in patients with APS compared with healthy controls and patients with non-SLE connective tissue diseases such as systemic sclerosis or Sjögren’s syndrome [62]. The gene discussed is C3; the disease is autoimmune polyendocrinopathy.